Home > Books > Book
Clinical Research Badge

Handbook of Research on Advancements in Cancer Therapeutics

Sumit Kumar (National Institute of Pathology, New Delhi, India), Moshahid Alam Rizvi (Jamia Millia Islamia, India), and Saurabh Verma (National Institute of Pathology, India)
Indexed In: SCOPUS
Release Date: November, 2020 | Copyright: © 2021 | Pages: 913

Publication Status: E-Book and Print Version Available for Purchase
ISBN13: 9781799865308
EISBN13: 9781799865315
DOI: 10.4018/978-1-7998-6530-8

Description:

The complexity of cancer demands an integrated approach from both a cancer biology standpoint and a pharmaceutical basis to understand the different anticancer modalities. Current research has been focused on conventional and newer anticancer modalities, recent discoveries in cancer research, and also the advancements in cancer treatment. There is a current need for more research on the advances in cancer therapeutics that bridge the gap between basic research (pharmaceutical drug development processes, regulatory issues, and translational experimentation) and clinical application. Recent promising discoveries such as immunotherapies, promising therapies undergoing clinical trials, synthetic lethality, carbon beam radiation, and other exciting targeted therapies are being studied to improve and advance the studies of modern cancer treatment.

The Handbook of Research on Advancements in Cancer Therapeutics serves as a comprehensive guide in modern cancer treatment by combining and merging the knowledge from both cancer biology and the pharmacology of anticancer modalities. The chapters come from multi-disciplinary backgrounds, including scientists and clinicians from both academia and various industries, to discuss nascent personalized therapies and big data-driven cancer treatment. While highlighting topic areas that include cancer prevention, cancer therapeutics, and cancer treatments through the lenses of technology, medicine/drugs, and alternate therapies, this book is ideally intended for oncologists, radiation oncologists, surgical oncologists, and cancer biologists, along with practitioners, stakeholders, researchers, academicians, and students who are interested in understanding the most fundamental aspects of cancer and the available therapeutic opportunities.

Coverage:

The many academic areas covered in this publication include, but are not limited to:

  • Anticancer Modalities
  • Bio-Imaging
  • Breast Cancer
  • Cancer Biology
  • Cancer Therapy
  • Drug Delivery
  • Gene Editing
  • Gene Therapies
  • Immunotherapy
  • Nanomedicine
  • Nutrition, Diet, and Cancer Prevention
  • Oncotherapy
  • Phytopharmaceuticals

Search this Book:
Reset

Indexing

Sumit Kumar is affiliated with the National Institute of Pathology.

Moshahid Alam Rizvi is affiliated with Jamia Millia Islamia.

Saurabh Verma is affiliated with the National Institute of Pathology.

All IGI Global Scientific Publishing content is archived via the CLOCKSS and LOCKSS initiative. Additionally, all IGI Global Scientific Publishing published content is available in the IGI Global Scientific Publishing InfoSci® platform.

We are committed to continually improving our platform to meet WCAG standards. We have used automated scans as well as manual review to identify and resolve compatibility issues. Our goal is to ensure all of our content is easily accessible to all users.

  • Current Accessibility Implementations
  • Screen reader compatible web pages with properly labeled elements.
  • Text alternatives for non-text content so it can be changed into large print, braille, speech, symbols, or simpler language.
  • User interface can be navigated using only a keyboard - no keyboard traps.
  • Consistent navigation on all web pages.
  • Meaningful section heading are used to organize content in a logical manner.
  • Logical focus order of elements on each web page.
  • No web pages contain any flashing, or design elements that are known to cause seizures or physical reactions.
  • Text has high contrast, with a contrast ratio of at least 4.5:1.
  • Responsive design, with text that can be resized without loss of content or functionality.
Learn More